Don't use anti-HIV drugs to treat seriously ill COVID-19 patients, Centre tells doctors

In the revised guidelines on management of COVID-19 patients, the Ministry of Health and Family Welfare said, "No specific antivirals have been proven to be effective as per currently available data"

Published: 01st April 2020 09:00 PM  |   Last Updated: 01st April 2020 09:00 PM   |  A+A-

An Indian woman who recently returned from the United States being examined by doctors at a novel coronavirus help desk at a hospital in Hyderabad

For representational purposes (Photo | Vinay Madapu, EPS)

Express News Service

NEW DELHI: The Centre has now asked doctors treating seriously ill patients of COVID-19 to stop giving them anti-HIV drugs, recommended earlier, and instead put them on a combination of anti-malaria drug hydroxycholoroquine and antibiotic azithromycin.

In the revised guidelines on the management of COVID-19 patients made public on Tuesday night, the Union Ministry of Health and Family Welfare said, “No specific antivirals have been proven to be effective as per currently available data.”

Earlier, it had recommended using the combination of Lopinavir-Ritonavir for treating COVID-19 patients with acute respiratory distress.

The government has now said that based on the available information (uncontrolled clinical trials), two drugs may be considered as an off-label indication in patients with severe disease and requiring intensive care unit management.

“One of the drugs is hydroxychloroquine (dose 400mg twice a day – for 1 day followed by 200mg twice a day for 4 days) in combination with azithromycin (500 mg once a day for 5 days),” said the guidelines.

“These drugs should be administered under close medical supervision, with monitoring for side-effects including QTc interval.”

The government also said that these medications are presently not recommended for children less than 12 years, pregnant and lactating women.

“These guidelines are based on currently available information and would be reviewed from time to time as new evidence emerges,” the ministry said.

Sources said that the revision has come as a study published in the New England Journal said that the anti-HIV drug combination did not work in 199 patients analysed while another study from France said that the anti-malarial and antibiotic combination helped 78 out of 80 patients analysed.

There was another independent study from China to support the hydroxycholoroquine-azithromycin combination.

Doctors treating infected patients meanwhile said that the combination should be taken only under close medical supervision.

“The government seems to have done a good thing by removing the recommendation on anti-HIV drugs for treating COVID-19 patients as the evidence in its support was very thin and its side-effects were harsh,” said Dr Yatin Mehta, head critical care specialists at Medanata hospital in Gurugram.

He, however added that HCQ and azithromycin should be given to patients under strict monitoring as it has cardio-toxicity effects in patients with underlying heart issues.

The government last week had recommended prophylactic usage of hydroxycholoroquine for healthcare workers treating novel coronavirus infected patients and close relatives of those who have tested positive—even though there is no good quality evidence that the drug, used in malaria, lupus and rheumatoid arthritis, can prevent infection from SARS CoV 2.

After that, there were many reports that people -- including doctors, even those not involved in treating COVID-19 patients -- had started consuming the drug. This included a 43-year-old doctor in Guwahati who apparently died after taking a few doses of hydroxychloroquine and azithromycin—as he was already on cardiac medication.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp